Literature DB >> 27563393

Inhibitors of BRD4 as Potential Cancer Therapy.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2016        PMID: 27563393      PMCID: PMC4983737          DOI: 10.1021/acsmedchemlett.6b00259

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  3 in total

Review 1.  Pathogenesis of NUT midline carcinoma.

Authors:  Christopher A French
Journal:  Annu Rev Pathol       Date:  2011-10-17       Impact factor: 23.472

Review 2.  BET bromodomain inhibitors: a patent review.

Authors:  Jean-Marc Garnier; Phillip P Sharp; Christopher J Burns
Journal:  Expert Opin Ther Pat       Date:  2013-11-22       Impact factor: 6.674

3.  BRD4: a BET(ter) target for the treatment of AML?

Authors:  Peter Valent; Johannes Zuber
Journal:  Cell Cycle       Date:  2014-01-21       Impact factor: 4.534

  3 in total
  3 in total

Review 1.  Targeting Brd4 for cancer therapy: inhibitors and degraders.

Authors:  Yingchao Duan; Yuanyuan Guan; Wenping Qin; Xiaoyu Zhai; Bin Yu; Hongmin Liu
Journal:  Medchemcomm       Date:  2018-08-07       Impact factor: 3.597

Review 2.  Bromodomain and BET family proteins as epigenetic targets in cancer therapy: their degradation, present drugs, and possible PROTACs.

Authors:  Mohd Muddassir; Kunjal Soni; Chetan B Sangani; Abdullah Alarifi; Mohd Afzal; Naaser A Y Abduh; Yongtao Duan; Poonam Bhadja
Journal:  RSC Adv       Date:  2020-12-24       Impact factor: 4.036

Review 3.  Drug Discovery Targeting Bromodomain-Containing Protein 4.

Authors:  Zhiqing Liu; Pingyuan Wang; Haiying Chen; Eric A Wold; Bing Tian; Allan R Brasier; Jia Zhou
Journal:  J Med Chem       Date:  2017-03-02       Impact factor: 7.446

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.